NA
PETS icon

Navellier & Associates’s PetMed Express PETS Stock Holding History

Navellier & Associates’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-40,162
Closed -$1.29M – 310
2020
Q4 		$1.29M Buy
40,162
+10,521
+35% +$324K 0.23% 105
2020
Q3 		$937K Buy
+29,641
New +$981K 0.2% 102

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.2B AUM 41.24% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Navellier & Associates's PETS Position: Q1 2021 in Review

Navellier & Associates sold out of PetMed Express (PETS) in Q1 2021, closing a stake of 40,162 shares — an estimated $1.29M sold.

Navellier & Associates first reported a position in PETS in Q3 2020 and held it in 2 quarters. The position peaked at $1.29M in Q4 2020. 205 funds tracked by Wall St. Rank hold PETS as of Q1 2021.

  • Navellier & Associates reported no remaining PetMed Express position as of Q1 2021 after selling out during the quarter.
  • Navellier & Associates sold 40,162 PetMed Express shares in Q1 2021, an estimated $1.29M.
  • Navellier & Associates first reported a position in PetMed Express in Q3 2020 and held it in 2 quarters.
  • Navellier & Associates's PetMed Express position peaked at $1.29M in Q4 2020.
  • 205 funds tracked by Wall St. Rank held PetMed Express as of Q1 2021.

Based on Navellier & Associates's 13F filing for Q1 2021, filed 12 May 2021.